je.st
news
InterMune shares jump as Boehringer's rival drug shows mixed results
2014-03-22 05:08:55| Biotech - Topix.net
Shares of InterMune Inc rose as much as 17 percent on Friday after data showed German drugmaker Boehringer Ingleheim's rival drug had mixed results in late-stage trials.
Tags: results
jump
shows
drug
Category:Biotechnology and Pharmaceuticals